Professional Summary

Professional Overview

Miao Wen is a seasoned professional with over a decade of experience in the biopharmaceutical industry. As the Director at Sutro Biopharma, Inc., she leverages her exceptional scientific expertise and leadership skills to drive innovation and contribute to the company's success.

Experience Summary

Current Role

As the Director at Sutro Biopharma, Inc., Miao Wen is responsible for leading cross-functional teams, overseeing complex research projects, and ensuring the delivery of high-quality biotherapeutics. Her strategic vision and proven track record of driving operational excellence have been instrumental in advancing the company's drug development pipeline.

Career Progression

Miao Wen has steadily progressed through her career, demonstrating a commitment to professional growth and a passion for her work. Prior to her current role, she served as an Associate Director and Sr. Scientist at Sutro Biopharma, Inc., where she made significant contributions to the development of novel biologics. Her earlier experience includes roles as a Scientist at Solazyme, Inc. and a Staff Scientist at UC Berkeley, where she honed her technical expertise and collaborative skills.

Academic Background

Miao Wen holds a Ph.D. in Molecular and Cell Biology from UC Berkeley, where her research focused on the development of innovative biotherapeutic approaches. Her academic achievements, including numerous peer-reviewed publications and industry presentations, have established her as a respected authority in the field.

Areas of Expertise

Miao Wen's areas of expertise include:

• Biotherapeutic drug development

• Protein engineering and optimization

• Antibody and antibody-drug conjugate (ADC) design

• Bioprocessing and scale-up

• Cross-functional team leadership and project management

Professional Impact

Throughout her career, Miao Wen has made significant contributions to the advancement of biopharmaceutical research and development. She has played a pivotal role in the successful development and clinical advancement of several novel biotherapeutic candidates, positively impacting patient outcomes and furthering the company's mission.

Conclusion

Miao Wen's exceptional scientific expertise, coupled with her visionary leadership and collaborative approach, make her a valuable asset to Sutro Biopharma, Inc. and the broader biopharmaceutical industry. Her commitment to innovation and her track record of delivering results position her for continued success in her current and future roles.